| EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries K Kotseva, D Wood, D De Bacquer, G De Backer, L Rydén, C Jennings, ... European journal of preventive cardiology 23 (6), 636-648, 2016 | 1308 | 2016 |
| Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 26 (8), 824-835, 2019 | 822 | 2019 |
| Ivabradine in stable coronary artery disease without clinical heart failure K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari New England Journal of Medicine 371 (12), 1091-1099, 2014 | 623 | 2014 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 323 | 2019 |
| Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries–findings from the EUROASPIRE IV survey Ž Reiner, G De Backer, Z Fras, K Kotseva, L Tokgözoglu, D Wood, ... Atherosclerosis 246, 243-250, 2016 | 244 | 2016 |
| Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary … K Kotseva, D De Bacquer, G De Backer, L Rydén, C Jennings, V Gyberg, ... European journal of preventive cardiology 23 (18), 2007-2018, 2016 | 221 | 2016 |
| Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology G De Backer, J Besseling, J Chapman, GK Hovingh, JJP Kastelein, ... Atherosclerosis 241 (1), 169-175, 2015 | 188 | 2015 |
| Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European … N Pogosova, K Kotseva, D De Bacquer, R von Känel, D De Smedt, ... European journal of preventive cardiology 24 (13), 1371-1380, 2017 | 160 | 2017 |
| Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme … K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 28 (4), 370-379, 2021 | 155 | 2021 |
| Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of … V Gyberg, D De Bacquer, G De Backer, C Jennings, K Kotseva, L Mellbin, ... Cardiovascular diabetology 14, 1-11, 2015 | 141 | 2015 |
| Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE Surveys, 1999–2013 K Kotseva, D De Bacquer, C Jennings, V Gyberg, G De Backer, L Rydén, ... Global heart 12 (4), 315-322. e3, 2017 | 136 | 2017 |
| Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a … V Gyberg, D De Bacquer, K Kotseva, G De Backer, O Schnell, J Sundvall, ... European heart journal 36 (19), 1171-1177, 2015 | 122 | 2015 |
| Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes G Fulcher, DR Matthews, V Perkovic, D De Zeeuw, KW Mahaffey, ... Diabetes, Obesity and Metabolism 18 (1), 82-91, 2016 | 105 | 2016 |
| The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention K Kotseva, Euroaspire Investigators Cardiovascular diagnosis and therapy 7 (6), 633, 2017 | 90 | 2017 |
| EUROASPIRE Investigators*. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology … K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... Eur J Prev Cardiol 26 (8), 824-835, 2019 | 84 | 2019 |
| EUROASPIRE Investigators EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European … K Kotseva, D Wood, D De Bacquer, G De Backer, L Rydén, C Jennings, ... Eur J Prev Cardiol 23 (6), 636-648, 2016 | 78 | 2016 |
| Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement … G Ferrannini, D De Bacquer, G De Backer, K Kotseva, L Mellbin, D Wood, ... Diabetes care 43 (4), 726-733, 2020 | 56 | 2020 |
| EUROASPIRE investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe … K Kotseva, D Wood, D De Bacquer Eur J Prev Cardiol 25 (12), 1242-1251, 2018 | 52 | 2018 |
| Депрессивные и тревожные расстройства при сердечно-сосудистых заболеваниях МН Долженко Практична ангіологія 2 (1), 17-23, 2006 | 43 | 2006 |
| Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology M Snaterse, JW Deckers, MJ Lenzen, HT Jorstad, D De Bacquer, ... International journal of cardiology 258, 1-6, 2018 | 40 | 2018 |
Kornelia KotsevaImperial College London UK在 imperial.ac.uk 的电子邮件经过验证
